Dr. Daniel L. Mulkerin, MD

  • Rochester, NY
  • Medical oncologist
NPI1063473411PAC ID7315003134
Medicare services, 2024
175
Medicare patients, 2024
41
Part D claims, 2024
119
Publications
31
Clinical trials
1
Practice address
601 Elmwood Ave, Rochester, NY 14642
Practice phone
Call (585) 275-2121
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Strong Memorial Hospital

Hospital · Rochester, New York

See all 5 affiliations

Find Dr. Mulkerin's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Daniel L. Mulkerin is a medical oncologist in Rochester, New York

Dr. Mulkerin practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. Mulkerin's NPI, 1063473411, was assigned on March 28, 2006. Dr. Mulkerin graduated from Sidney Kimmel Medical College at Thomas Jefferson University in 1992. Dr. Mulkerin holds Wisconsin license 34545.

NPI and contact details
Medicare PAC ID
7315003134
NPI enumeration date
March 28, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(585) 275-2121
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
60
Medical school graduation
1992

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Daniel L. Mulkerin practices at Strong Memorial Hospital in Rochester, New York

Dr. Mulkerin's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Source: Dmand AI Affiliation Data

Dr. Daniel L. Mulkerin is affiliated with 2 sites of care and 3 medical groups

Dr. Mulkerin's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Mulkerin to 2 more medical groups and 1 hospice, each named with a free account.

See all 5 affiliations for Dr. Mulkerin

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Daniel L. Mulkerin's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mulkerin practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Strong Memorial HospitalAvailable with a free account
+1 more site and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Mulkerin practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Rochester Medical Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Daniel L. Mulkerin is one of 458 medical oncologists in New York

Medical oncology is Dr. Mulkerin's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Mulkerin's licenses on file in 2 states: Wisconsin and New York.

Specialties and state licenses

  • Medical oncology, WisconsinPrimaryLicense 34545 · taxonomy 207RX0202X
  • New York licenseLicense 311315

Medical oncologists near Dr. Mulkerin

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Daniel L. Mulkerin billed Medicare for 175 services in 2024

CMS data shows 175 Medicare services from Dr. Mulkerin across 2 procedure codes in 2024, for 41 Medicare patients. Medicare paid $12,154 for them.

Medicare services, 2024175
Medicare patients41
Paid by Medicare$12,154
Procedure codes2

Dr. Mulkerin's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1052024: 1127%
Other services
2023: 02024: 63

Where Dr. Mulkerin's Medicare services took place, 2024

  • In an office10459%
  • In a facility7141%

Dr. Mulkerin compared with the New York median for medical oncologists, 2024

  • Dr. Mulkerin
  • New York median
Medicare services
175vs 34049% below
Medicare patients
41vs 11263% below
Part D claims
52vs 13060% below

Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.

Dr. Mulkerin's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Mulkerin

Need commercial claims for Dr. Mulkerin?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mulkerin and other medical oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Daniel L. Mulkerin treated 41 Medicare patients in 2024, average age 73

CMS counts 41 Medicare patients who saw Dr. Mulkerin in 2024. The largest group is 65 to 74, with 19 patients. 71% of them have high blood pressure, and 59% have high cholesterol. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mulkerin's median patient age at 69, with 46% women.

Medicare patients, 202441
Average age73
Average risk score1.83

Dr. Mulkerin's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Mulkerin's Medicare patients by sex, 2024

  • Women1537%
  • Men2663%

Chronic conditions among Dr. Mulkerin's Medicare patients, 2024

  1. High blood pressure71%
  2. High cholesterol59%
  3. Arthritis41%
  4. Diabetes32%
  5. Mood disorders29%
  6. Anxiety27%
  7. Depression27%

Share of Medicare patients with each condition. A patient can have several.

Dr. Mulkerin's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women46%
  • Men54%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Daniel L. Mulkerin wrote 119 Medicare Part D claims in 2024

In 2024, Dr. Mulkerin wrote 119 Medicare Part D claims for 46 patients. 79% of them were for generic drugs. CMS names the drug for 52 of them, across 3 drugs with 11 or more claims each, at $154,972 in total drug cost. In 2023, CMS named 77 claims across 3 drugs.

Part D claims, 2024119
Drugs named by CMS3
Total drug cost$154,972
Part D patients46

Dr. Mulkerin's Part D claims by kind of drug, 2024

  • Generic94 claims79%
  • Brand-name25 claims21%

Dr. Mulkerin's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Mulkerin's Part D claims, 2024

  • Opioids16%19 of 119 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 772024: 5232%

Drugs named by CMS: 3 in 2024, 3 in 2023.

See all prescribing by Dr. Mulkerin

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Daniel L. Mulkerin offers telehealth to Medicare patients

Dr. Mulkerin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mulkerin as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find medical oncologists like Dr. Mulkerin by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Daniel L. Mulkerin has 31 publications on record

Dmand AI links 31 papers to Dr. Mulkerin, published from 2010 to 2025. 2015 was the busiest year, with 3. The most frequent topics are Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols and Pancreatic Neoplasms. Dr. Mulkerin has published most often in Invest New Drugs. Dr. Mulkerin's most frequent co-authors are Sam Joseph Lubner, MD, William R. Schelman, MD, PhD and Glenn Liu, MD.

Papers31
Years published2010 to 2025

Dr. Mulkerin's papers by year, 2013 to 2025

Topics Dr. Mulkerin writes about most

  • Antineoplastic Agents
  • Antineoplastic Combined Chemotherapy Protocols
  • Pancreatic Neoplasms
  • Capecitabine
  • Neuroendocrine Tumors
  • Organoplatinum Compounds
  • Adenocarcinoma
  • Cancer Care Facilities

Dr. Mulkerin's most frequent co-authors

Recent publications by Dr. Mulkerin

See all 31 publications and co-authors

See who Dr. Mulkerin researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mulkerin works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Daniel L. Mulkerin has worked on 1 clinical trial

Dmand AI links Dr. Mulkerin to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Rectal Diseases and Colorectal Neoplasms.

Conditions in Dr. Mulkerin's trials

  • Rectal Diseases
  • Colorectal Neoplasms

Investigators on the most trials with Dr. Mulkerin

Recent clinical trials with Dr. Mulkerin

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Daniel L. Mulkerin received $1,039 in industry payments from 2016 to 2020

CMS Open Payments shows 8 general payments to Dr. Mulkerin from 4 drug and device companies from 2016 to 2020. Travel and lodging make up the largest share, 52% of the total. Eli Lilly and Company paid the most, $646.

General payments to Dr. Mulkerin by program year, 2016 to 2020

General payments to Dr. Mulkerin by kind, 2016 to 2020

$1Kin total
  • Travel and lodging$54252%
  • Food and beverage$48246%
  • Speaker and faculty fees$151%

Companies that paid Dr. Mulkerin the most, 2016 to 2020

Share is of all general payments to this clinician.

See all payments to Dr. Mulkerin

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Daniel L. Mulkerin graduated from Sidney Kimmel Medical College at Thomas Jefferson University

Dr. Mulkerin graduated from Sidney Kimmel Medical College at Thomas Jefferson University in 1992.

  1. Medical schoolSidney Kimmel Medical College at Thomas Jefferson University

Source: Dmand AI Professional Profile Data

Sources for Dr. Daniel L. Mulkerin's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Daniel L. Mulkerin

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Daniel L. Mulkerin's NPI number?

Dr. Daniel L. Mulkerin's NPI number is 1063473411. It was assigned on March 28, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Daniel L. Mulkerin?

Dr. Daniel L. Mulkerin is a medical oncologist in Rochester, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Daniel L. Mulkerin practice?

Dr. Mulkerin practices at 601 Elmwood Ave, Rochester, NY 14642. Dr. Mulkerin's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. Dmand AI also links Dr. Mulkerin to 2 medical groups and 1 hospice.

What is Dr. Daniel L. Mulkerin's office phone number?

The practice phone on file for Dr. Mulkerin is (585) 275-2121.

What is Dr. Daniel L. Mulkerin's medical license number?

Dr. Mulkerin holds Wisconsin license 34545, one of the licenses on file in 2 states.

Which states has Dr. Daniel L. Mulkerin been licensed in?

Dmand AI has state licenses on file for Dr. Mulkerin in Wisconsin and New York.

Which hospitals is Dr. Daniel L. Mulkerin affiliated with?

Dr. Mulkerin practices at Strong Memorial Hospital in Rochester, New York.

What medical group is Dr. Daniel L. Mulkerin part of?

Dr. Mulkerin is linked to University of Rochester Medical Faculty Group (URMFG). Dmand AI links Dr. Mulkerin to 2 more medical groups.

Does Dr. Daniel L. Mulkerin accept Medicare?

Yes. CMS data shows Dr. Mulkerin billed Medicare for 175 services in 2024, and Dr. Mulkerin accepts Medicare assignment.

Does Dr. Daniel L. Mulkerin offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Mulkerin as offering telehealth services.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Daniel L. Mulkerin see?

CMS counts 41 Medicare patients who saw Dr. Mulkerin in 2024, with an average age of 73.

What services does Dr. Daniel L. Mulkerin bill to Medicare?

In 2024, Dr. Mulkerin's most billed Medicare services were office visit, established patient (99215) and medicare service (G2211).

Where did Dr. Daniel L. Mulkerin go to medical school?

Dr. Mulkerin graduated from Sidney Kimmel Medical College at Thomas Jefferson University in 1992.

What drugs does Dr. Daniel L. Mulkerin prescribe most?

In 2024 Medicare Part D data, Dr. Mulkerin's most prescribed drugs by claims were Prochlorperazine Maleate, Ondansetron HCl and Lonsurf.

Has Dr. Daniel L. Mulkerin received payments from drug or device companies?

CMS Open Payments shows $1,039 in general payments to Dr. Mulkerin from 4 companies from 2016 to 2020. The largest total came from Eli Lilly and Company.

How long has Dr. Daniel L. Mulkerin been practicing?

Dr. Mulkerin graduated from medical school in 1992, 34 years ago.

Does Dr. Daniel L. Mulkerin do research?

Dmand AI links 31 publications to Dr. Mulkerin, published from 2010 to 2025. Dr. Mulkerin has worked on 1 clinical trial.

Who does Dr. Daniel L. Mulkerin publish with?

Dr. Mulkerin's most frequent co-authors are Sam Joseph Lubner, MD (15 shared papers), William R. Schelman, MD, PhD (5 shared papers) and Glenn Liu, MD (4 shared papers).

Selling to medical oncology practices?

See medical oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)